BioStock: Alligator Bioscience enters collaboration with Orion Corporation

We found out this week that Alligator Bioscience’s immuno-oncology technology platform RUBY has caught the eye of Orion Corporation, a global pharma company dedicated to developing new treatments for cancer patients. The research collaboration signed between the two companies will focus on the discovery of novel bispecific antibodies directed towards immuno-oncology targets selected by Orion. 

Read the article at biostock.se:

https://www.biostock.se/2021/08/alligator-bioscience-enters-collaboration-with-orion-corporation/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se/